GLP-1/Exendin-4 induces β-cell proliferation via the epidermal growth factor receptor
Abstract Exendin-4 is a long acting glucagon-like peptide 1 (GLP-1) analogue that is an agonist for the GLP-1 receptor, a G-protein coupled receptor (GPCR). Exendin-4 is used to clinically improve glucose tolerance in diabetic patients due to its ability to enhance insulin secretion. In rodents, and...
Main Authors: | Joseph Fusco, Xiangwei Xiao, Krishna Prasadan, Qingfeng Sheng, Congde Chen, Yung-Ching Ming, George Gittes |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-09898-4 |
Similar Items
-
Neuroprotective effect of GLP-1 receptor agonist Exendin-4 in rat models of Parkinson's disease
by: Harkavyi, Alexander
Published: (2009) -
Evaluation of an [18F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in Insulinoma
by: Dale O. Kiesewetter, Ning Guo, Jinxia Guo, Haokao Gao, Lei Zhu, Ying Ma, Gang Niu, Xiaoyuan Chen
Published: (2012-01-01) -
[68Ga]Exendin-4: Bench-to-Bedside : PET molecular imaging of the GLP-1 receptor for diabetes and cancer
by: Selvaraju, Ram kumar
Published: (2015) -
Gut peptide GLP-1 and its analogue, Exendin-4, decrease alcohol intake and reward.
by: Rozita H Shirazi, et al.
Published: (2013-01-01) -
Grape powder attenuates the negative effects of GLP-1 receptor antagonism by exendin-3 (9-39) in a normoglycemic mouse model
by: Haufe, Thomas Carl
Published: (2017)